Empagliflozin Reverses Late Na+Current Enhancement and Cardiomyocyte Proarrhythmia in a Translational Murine Model of Heart Failure with Preserved Ejection Fraction

Bence Hegyi, Juliana Mira Hernandez, Erin Y. Shen, Nima R. Habibi, Julie Bossuyt, Donald M. Bers

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1029-1031
Number of pages3
Issue number13
StatePublished - Mar 29 2022


  • arrhythmia, cardiac
  • empagliflozin
  • heart failure, diastolic
  • sodium channels
  • sodium-glucose transporter 2 inhibitors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this